Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Gains from Investment Securities (2022 - 2025)

OneMedNet (ONMD) has disclosed Gains from Investment Securities for 4 consecutive years, with -$822000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities fell 13800.0% to -$822000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $18000.0, a 92.72% decrease, with the full-year FY2023 number at -$129000.0, down 114.12% from a year prior.
  • Gains from Investment Securities was -$822000.0 for Q3 2025 at OneMedNet, down from $314000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $531000.0 in Q1 2025 to a low of -$2.8 million in Q1 2022.
  • A 4-year average of -$351984.9 and a median of $500.0 in 2024 define the central range for Gains from Investment Securities.
  • Biggest YoY gain for Gains from Investment Securities was 7685.71% in 2025; the steepest drop was 13800.0% in 2025.
  • OneMedNet's Gains from Investment Securities stood at -$245217.0 in 2022, then surged by 198.81% to $242291.0 in 2023, then crashed by 102.06% to -$5000.0 in 2024, then tumbled by 16340.0% to -$822000.0 in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Gains from Investment Securities are -$822000.0 (Q3 2025), $314000.0 (Q2 2025), and $531000.0 (Q1 2025).